SCHEMBL14723787

SCHEMBL14723787

O=C(Nc1ccc(-c2ccc(NC(=O)[C@@H]3CCCN3C(=O)[C@H]3CCCO3)cc2)cc1)C1CC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.50
ALDH1A1 P00352 5/20 0.50
POLB P06746 4/20 0.50
F2 P00734 1/20 0.48
PTPN1 P18031 2/20 0.48
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
TP53 P04637 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP2C9 P11712 1/20 0.46
LMNA P02545 3/20 0.46
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
GLA P06280 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17474773 0.95 HPGD (0.54) HPGDALDH1A1POLBF2NPC1
SCHEMBL17488503 0.95 HPGD (0.54) HPGDALDH1A1POLBF2NPC1
SCHEMBL13379357 0.90 NPC1 (0.50) HPGDALDH1A1POLBF2NPC1
SCHEMBL845120 0.90 HPGD (0.47) HPGDALDH1A1POLBF2NPC1
SCHEMBL18887497 0.87 HPGD (0.46) HPGDALDH1A1POLBF2NPC1
SCHEMBL845476 0.87 HPGD (0.46) HPGDALDH1A1POLBF2NPC1
SCHEMBL2192575 0.86 HPGD (0.65) HPGDALDH1A1POLBF2NPC1
SCHEMBL14827626 0.86 HPGD (0.65) HPGDALDH1A1POLBF2NPC1
SCHEMBL14648037 0.86 HPGD (0.65) HPGDALDH1A1POLBF2NPC1
SCHEMBL14648053 0.86 HPGD (0.65) HPGDALDH1A1POLBF2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383094-B2 inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials BRISTOL-MYERS SQUIBB COMPANY (US) 2013-02-26 US disclosed